IP Library › Granted Patent US 9,168,373
Granted Patent B2
US 9,168,373 · App. 12/280,280 · Granted Oct 27, 2015

Nanosecond pulsed electric fields cause melanomas to self-destruct

Inventors: Richard Nuccitelli (Norfolk, VA); Stephen J. Beebe (Norfolk, VA); Karl H. Schoenbach (Norfolk, VA)
Assignees: Eastern Virginia Medical School; Old Dominion University Research Foundation
A61N1/327
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,168,373
App. No.
12/280,280
Granted
Oct 27, 2015
Kind
B2
Abstract

Methods for a new, drug-free therapy for treating solid skin tumors through the application of nanosecond pulsed electric fields (“nsPEFs”) are provided. In one embodiment of the invention, the cells are melanoma cells, and the applied nsPEFs penetrate into the interior of tumor cells and cause tumor cell nuclei to rapidly shrink and tumor blood flow to stop. This new technique provides a highly localized targeting of tumor cells with only minor effects on overlying skin.

Claims (20)

1. A method for selectively initiating apoptosis in melanoma cells in a tissue comprising:

coating a skin tissue overlying melanoma cells with a composition that reduces flashover during pulse field application; and

applying at least 100 nsPEFs to said tissue comprising melanoma cells, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 20 kV/cm and no more than about 350 kV/cm.

2. The method of claim 1 , whereby said method is carried out in situ.

3. The method of claim 1 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds and an electric field strength of at least about 20 kV/cm and no more than about 40 kV/cm.

4. The method of claim 1 , wherein said method is repeated one or more times.

5. The method of claim 4 , wherein the method is repeated two to three weeks after initially applying the at least 100 nsPEFs.

6. A method for inhibiting blood flow in a tissue comprising melanoma cells comprising:

coating a skin tissue overlying melanoma cells with a composition that reduces flashover during pulse field application; and

applying at least 100 nsPEFs to said tissue, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 20 kV/cm and no more than about 350 kV/cm.

7. The method of claim 6 , whereby said method is carried out in situ.

8. The method of claim 6 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds and an electric field pulse strength of at least about 20 kV/cm and no more than about 40 kV/cm.

9. The method of claim 6 , wherein said method is repeated one or more times.

10. The method of claim 6 , wherein said tissue is selected from the group consisting of fat, bone, skin, muscle, cartilage or a combination thereof.

11. A method for inducing tumor regression comprising;

coating a skin tissue overlying melanoma cells with a composition that reduces flashover during pulse field application; and

applying at least 100 nsPEFs to said tumor of melanoma cell origin, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 20 kV/cm and no more than about 350 kV/cm.

12. The method of claim 11 , whereby said method is carried out in situ.

13. The method of claim 11 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds and an electric field pulse strength of at least about 20 kV/cm and no more than about 40 kV/cm.

14. The method of claim 11 , wherein said method is repeated one or more times.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2024
From: EASTERN VIRGINIA MEDICAL SCHOOL
To: OLD DOMINION UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 068364/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2011
From: OLD DOMINION UNIVERSITY
To: OLD DOMINION UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 025810/0386 →
CONFIRMATORY LICENSE Recorded Feb 17, 2009
From: EASTERN VIRGINIA MEDICAL SCHOOL
To: UNITED STATES AIR FORCE
Reel/Frame 022276/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2008
From: NUCCITELLI, RICHARD; SCHOENBACH, KARL H.
To: OLD DOMINION UNIVERSITY
Reel/Frame 021464/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2008
From: BEEBE, STEPHEN J.
To: EASTERN VIRGINIA MEDICAL SCHOOL
Reel/Frame 021464/0297 →
Continuity (2)
Provisional Application 60776215 · Feb 24, 2006
Related Publication 20110092973A1 · Apr 21, 2011